GILEAD SCIENCES SL
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- $95.8B
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy
- Conditions
- Endometrial Cancer
- Interventions
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 520
- Registration Number
- NCT06486441
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸City of Hope, Duarte, California, United States
🇺🇸UC San Diego Medical Center, La Jolla, California, United States
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
- Conditions
- HIV-1-infection
- Interventions
- Drug: F/TAF (High Dose Tablet)Drug: B/F/TAF (Low Dose)Drug: E/C/F/TAF (Low Dose)Drug: F/TAF (Low Dose Tablet)Drug: F/TAF (Lowest Dose Tablet)Drug: F/TAF (High Dose TOS)Drug: B/F/TAF (High Dose)Drug: F/TAF (Low Dose TOS)Drug: B/F/TAF (Lowest Dose TOS)Drug: F/TAF (Lowest Dose TOS)Drug: B/F/TAF (High Dose TOS)Drug: 3rd ARV AgentDrug: B/F/TAF (Low Dose TOS)Drug: Nucleos(t)ide reverse transcriptase inhibitors (NRTI)Drug: ATVDrug: DRV
- First Posted Date
- 2024-03-29
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 350
- Registration Number
- NCT06337032
- Locations
- 🇿🇼
University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe
🇦🇷Helios Salud, Buenos Aires, Argentina
🇵🇦Hospital del Niño, Panama City, Panama
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy
- Conditions
- HIV-1-infection
- Interventions
- Drug: B/F/TAFDrug: Placebo to match B/F/TAFDrug: Placebo to match BIC/LEN
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 577
- Registration Number
- NCT06333808
- Locations
- 🇺🇸
Pueblo Family Physicians, Phoenix, Arizona, United States
🇺🇸Be Well Medical Center, Berkeley, California, United States
🇺🇸Pacific Oaks Medical Group, Beverly Hills, California, United States
Study of GS-1427 in Participants With Moderately to Severely Active UC
- Conditions
- Ulcerative Colitis (UC)
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Gilead Sciences Inc.
- Target Recruit Count
- 84
- Registration Number
- 2023-508304-38-00
- Locations
- 🇩🇪
Universitaetsklinikum Ulm AöR, Ulm, Germany
🇩🇪Studiengesellschaft BSF UG (haftungsbeschraenkt), Halle (Saale), Germany
🇩🇪Universitaetsklinikum Schleswig-Holstein AöR, Kiel, Germany
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
- Conditions
- Advanced Solid Tumors
- Interventions
- First Posted Date
- 2023-12-12
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 254
- Registration Number
- NCT06167317
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸NEXT Austin, Austin, Texas, United States
🇺🇸The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER)
- Conditions
- HIV-1-infection
- Interventions
- Drug: B/F/TAF
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 33
- Registration Number
- NCT06104306
- Locations
- 🇺🇸
Franco Felizarta, MD, Bakersfield, California, United States
🇺🇸BIOS Clinical Research, Palm Springs, California, United States
🇺🇸UC San Diego AntiViral Research Center (AVRC), San Diego, California, United States
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)
- Conditions
- Pre-Exposure Prophylaxis of HIV Infection
- Interventions
- Drug: Emtricitabine/tenofovir disoproxil fumarate (F/TDF)
- First Posted Date
- 2023-10-26
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 180
- Registration Number
- NCT06101342
- Locations
- 🇺🇸
UCLA Vine Street Clinic, Los Angeles, California, United States
🇺🇸UCSD AntiViral Research Center (AVRC), San Diego, California, United States
🇺🇸University of Miami - Converge Miami Building, Miami, Florida, United States
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)
- Conditions
- Pre-Exposure Prophylaxis of HIV Infection
- Interventions
- Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF)
- First Posted Date
- 2023-10-26
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 250
- Registration Number
- NCT06101329
- Locations
- 🇺🇸
George Washington University Medical Faculty Associates, Washington, District of Columbia, United States
🇺🇸UAB, 1917 Research Clinic, Birmingham, Alabama, United States
🇺🇸UCSD Antiviral Research Center (AVRC), San Diego, California, United States
Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 120
- Registration Number
- NCT06082960
- Locations
- 🇺🇸
Smilow Cancer Hospital Phase 1 Unit, New Haven, Connecticut, United States
🇺🇸SCRI Oncology Partners, Nashville, Tennessee, United States
🇺🇸NEXT Oncology, San Antonio, Texas, United States
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 318
- Registration Number
- NCT06051617
- Locations
- 🇺🇸
OM Research LLC, Lancaster, California, United States
🇺🇸SCPMG/Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
🇺🇸Cedar Sinai Medical Center, Los Angeles, California, United States